Literature DB >> 27029237

Comparing guideline-based care quality for inflammatory bowel disease and rheumatoid arthritis patients within a medical home.

Freddy Caldera1, Sumona Saha1, Arnold Wald1, David M Cooley2, Ying-Qi Zhao3, Zhanhai Li3, Christie M Bartels4.   

Abstract

BACKGROUND: Rheumatoid arthritis (RA) and inflammatory bowel disease (IBD) patient populations face similar risks of chronic immunosuppression including corticosteroid use. We compared the receipt of preventive services between IBD and RA populations according to published quality metrics.
METHODS: We defined a single-center cohort of patients with IBD or RA receiving specialty and primary care. Electronic health record abstraction assessed quality metrics, sociodemographics, comorbidity, and utilization. Comparisons used multivariate odds ratios and Student's t-tests.
RESULTS: 218 RA and 190 IBD patients were included. In multivariate analysis, IBD patients were less likely to receive pneumococcal vaccination (OR=0.29, 95% CI: 0.11-0.85), while RA patients underwent glucocorticoid-induced osteoporosis screening more often (100% vs. 82.5%, p = 0.023).
CONCLUSIONS: Gastroenterologists can improve care quality for IBD patients by assuming greater responsibility for preventive care in IBD patients and/or collaborating with primary care and health systems to improve preventive care delivery.

Entities:  

Keywords:  Inflammatory bowel disease; preventive care; quality care; rheumatoid arthritis; vaccination

Mesh:

Substances:

Year:  2016        PMID: 27029237      PMCID: PMC4970643          DOI: 10.1586/17474124.2016.1169920

Source DB:  PubMed          Journal:  Expert Rev Gastroenterol Hepatol        ISSN: 1747-4124            Impact factor:   3.869


  38 in total

1.  Screening for tuberculosis and hepatitis B prior to the initiation of anti-tumor necrosis therapy.

Authors:  Byron P Vaughn; Glen A Doherty; Shiva Gautam; Alan C Moss; Adam S Cheifetz
Journal:  Inflamm Bowel Dis       Date:  2011-09-26       Impact factor: 5.325

2.  What kills patients with rheumatoid arthritis?

Authors:  C Kelly; J Hamilton
Journal:  Rheumatology (Oxford)       Date:  2006-09-26       Impact factor: 7.580

3.  Increased risk of pneumonia among patients with inflammatory bowel disease.

Authors:  Millie D Long; Christopher Martin; Robert S Sandler; Michael D Kappelman
Journal:  Am J Gastroenterol       Date:  2013-01-08       Impact factor: 10.864

4.  Vaccinating the inflammatory bowel disease patient: deficiencies in gastroenterologists knowledge.

Authors:  Sharmeel K Wasan; Jennifer A Coukos; Francis A Farraye
Journal:  Inflamm Bowel Dis       Date:  2011-04-28       Impact factor: 5.325

5.  Are primary care providers uncomfortable providing routine preventive care for inflammatory bowel disease patients?

Authors:  Lisbeth Selby; Andrew Hoellein; John F Wilson
Journal:  Dig Dis Sci       Date:  2010-07-29       Impact factor: 3.199

6.  Combination therapy with infliximab and azathioprine is superior to monotherapy with either agent in ulcerative colitis.

Authors:  Remo Panaccione; Subrata Ghosh; Stephen Middleton; Juan R Márquez; Boyd B Scott; Laurence Flint; Hubert J F van Hoogstraten; Annie C Chen; Hanzhe Zheng; Silvio Danese; Paul Rutgeerts
Journal:  Gastroenterology       Date:  2014-02       Impact factor: 22.682

7.  Comparison of methotrexate monotherapy with a combination of methotrexate and etanercept in active, early, moderate to severe rheumatoid arthritis (COMET): a randomised, double-blind, parallel treatment trial.

Authors:  Paul Emery; Ferdinand C Breedveld; Stephen Hall; Patrick Durez; David J Chang; Deborah Robertson; Amitabh Singh; Ronald D Pedersen; Andrew S Koenig; Bruce Freundlich
Journal:  Lancet       Date:  2008-07-16       Impact factor: 79.321

Review 8.  A practical guide to vaccinating the inflammatory bowel disease patient.

Authors:  Sharmeel K Wasan; Stacey E Baker; Paul R Skolnik; Francis A Farraye
Journal:  Am J Gastroenterol       Date:  2010-01-26       Impact factor: 10.864

9.  Clinician's Guide to Prevention and Treatment of Osteoporosis.

Authors:  F Cosman; S J de Beur; M S LeBoff; E M Lewiecki; B Tanner; S Randall; R Lindsay
Journal:  Osteoporos Int       Date:  2014-08-15       Impact factor: 4.507

10.  Effect of the early use of the anti-tumor necrosis factor adalimumab on the prevention of job loss in patients with early rheumatoid arthritis.

Authors:  Victoria Bejarano; Mark Quinn; Philip G Conaghan; Richard Reece; Anne-Maree Keenan; David Walker; Andrew Gough; Michael Green; Dennis McGonagle; Ade Adebajo; Stephen Jarrett; Sheelagh Doherty; Lesley Hordon; Richard Melsom; Kristina Unnebrink; Hartmut Kupper; Paul Emery
Journal:  Arthritis Rheum       Date:  2008-10-15
View more
  3 in total

1.  Guideline recommendations for treatment of patients with inflammatory bowel diseases are not implemented in clinical practice-results of a non-representative survey.

Authors:  Lea I Kredel; Oliver Schneidereit; Jörg C Hoffmann; Britta Siegmund; Jan C Preiß
Journal:  Int J Colorectal Dis       Date:  2018-12-07       Impact factor: 2.571

Review 2.  Healthcare maintenance in elderly patients with inflammatory bowel disease.

Authors:  Manish P Shrestha; Joannie Ruel; Sasha Taleban
Journal:  Ann Gastroenterol       Date:  2017-02-17

3.  Identifying Patients With Inflammatory Bowel Diseases in an Administrative Health Claims Database: Do Algorithms Generate Similar Findings?

Authors:  Yizhou Ye; Sudhakar Manne; Dimitri Bennett
Journal:  Inquiry       Date:  2019 Jan-Dec       Impact factor: 1.730

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.